We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SPCB:NASDAQSuperCom, Ltd. Analysis

Data as of 2026-09-02 - not real-time

$10.27

Latest Price

9/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind SuperCom Ltd. is neutral at $10.27, with no clear ordering between short and long averages. The last 30 days have lost 6.9%. Relative strength is 43.4 — neutral — and the MACD signal is bearish. Recent trading has carved out support near $9.87 and resistance around $11.97.
Valuation screens as undervalued: a P/E of 13.7 sits below the sector average of 28.6. Sell-side targets cluster 65.5% above the current quote. Revenue is growing at 13.3% on a 2.9% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 51.9%, a beta of 1.86 and a maximum drawdown of 45.4%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Near-term and long-term part ways here — hold short-term against buy longer out, with 6/10 conviction on the long call.

Top Market Events

SuperCom NASDAQ: SPCB , a global provider of secure solutions for the e-Government, IoT, and Cybersecurity sectors,...SuperCom SPCB is scheduled to announce Q2 earnings results on Thursday, August 13th, before market open.SuperCom NASDAQ: SPCB , a global provider of secured solutions for the e-Government, IoT and Cybersecurity sectors,...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Trading above the 200-day average of 9.64
  • MACD momentum is negative
  • 30-day price change of -6.9%

Medium Term

1–3 years
Positive
Model confidence: 4/10

Key Factors

  • P/E of 13.7 versus sector average of 28.6
  • Trading above the 200-day average of 9.64
  • Analyst targets imply +65.5% versus the current price

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 13.7 versus sector average of 28.6
  • Analyst targets imply +65.5% versus the current price
  • Revenue growth of +13.3%

Key Metrics & Analysis

Financial Health

Revenue Growth13.30%
Profit Margin2.92%
P/E Ratio13.7
ROE2.02%
ROA-0.49%
Debt/Equity48.45
P/B Ratio1.2
Industry P/E28.6

Technical Analysis

TrendNeutral
RSI43.4
Support$9.87
Resistance$11.97
MA 20$10.78
MA 50$10.90
MA 200$9.64
MACDBearish
VolumeStable
Fear & Greed Index92.25

Valuation

Target Price$17.00
Upside/Downside65.53%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.86
Volatility51.85%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.